Your browser doesn't support javascript.
loading
Use of transfer factor in immunosuppressed surgical patients.
Garritano, Celia Regina Oliveira; Nubila, Francesco di; Couto, Renata M; Fiorelli, Rossano Kepler Alvim; Aun, Luciana Berti.
Afiliação
  • Garritano CRO; - Federal University of the State of Rio de Janeiro (UNIRIO), Department of General and Specialized Surgery / Master's Degree in Medicine, Rio de Janeiro, RJ, Brazil.
  • Nubila FD; - Federal University of the State of Rio de Janeiro (UNIRIO), Department of General and Specialized Surgery / Master's Degree in Medicine, Rio de Janeiro, RJ, Brazil.
  • Couto RM; - Federal University of the State of Rio de Janeiro (UNIRIO), Department of General and Specialized Surgery / Master's Degree in Medicine, Rio de Janeiro, RJ, Brazil.
  • Fiorelli RKA; - Federal University of the State of Rio de Janeiro (UNIRIO), Department of General and Specialized Surgery / Master's Degree in Medicine, Rio de Janeiro, RJ, Brazil.
  • Aun LB; - Federal University of the State of Rio de Janeiro (UNIRIO), Department of General and Specialized Surgery / Master's Degree in Medicine, Rio de Janeiro, RJ, Brazil.
Rev Col Bras Cir ; 44(5): 452-456, 2017.
Article em En, Pt | MEDLINE | ID: mdl-29019573
OBJECTIVE: to evaluate the action of Transfer Factor on the immune response of patients with malignant neoplasm submitted to surgery, chemotherapy and radiotherapy. METHOD: we analyzed the variations of leukocytes, total lymphocytes, T-lymphocytes and CD4 counts in 60 patients submitted to immunostimulation with a single, daily dose of 0.5mg sublingual Transfer Factor, started simultaneously with chemotherapy and/or radiotherapy. RESULTS: there were statistically significant increases in the counts of all cell lines studied, more pronounced after 12 months of use of the medication. CONCLUSION: the Transfer Factor restored immune response and showed no side effects.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Transferência / Hospedeiro Imunocomprometido / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En / Pt Revista: Rev Col Bras Cir Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Transferência / Hospedeiro Imunocomprometido / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En / Pt Revista: Rev Col Bras Cir Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil